Variant report
| Variant | nsv524344 |
|---|---|
| Chromosome Location | chr7:103375437-103379897 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
(count:4 , 50 per page) page:
1
| No. | Distal block | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr7:103373703..103377683-chr7:103378422..103380704,3 | K562 | blood: | |
| 2 | chr7:103374430..103376979-chr7:103378353..103381015,4 | K562 | blood: | |
| 3 | chr7:103374430..103376979-chr7:103378353..103381015,4 | K562 | blood: | |
| 4 | chr7:103373703..103377683-chr7:103378422..103380704,3 | K562 | blood: |
| No data |
| No data |
| No data |
| No data |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs10487167 | chr7:103375437-103375438 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 2 | rs578061227 | chr7:103375479-103375480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs550775356 | chr7:103375509-103375510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs377513033 | chr7:103375515-103375516 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs17155053 | chr7:103375537-103375538 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 6 | rs545045214 | chr7:103375541-103375542 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs569538075 | chr7:103375577-103375578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs144256602 | chr7:103375592-103375593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs373405427 | chr7:103375637-103375638 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs188805597 | chr7:103375732-103375733 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs558207742 | chr7:103375735-103375736 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs576501914 | chr7:103375770-103375771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs376389167 | chr7:103375789-103375790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs148707138 | chr7:103375792-103375793 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs141578774 | chr7:103375825-103375826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs117660949 | chr7:103375835-103375836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs7797966 | chr7:103375846-103375847 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 18 | rs561369390 | chr7:103375860-103375861 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs576484239 | chr7:103375867-103375868 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs7798224 | chr7:103375873-103375874 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 21 | rs541768 | chr7:103375920-103375921 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 22 | rs139713852 | chr7:103375930-103375931 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs113704406 | chr7:103375931-103375932 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs191059889 | chr7:103375993-103375994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs374355790 | chr7:103376007-103376008 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs144438294 | chr7:103376053-103376054 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs116493055 | chr7:103376079-103376080 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs146115230 | chr7:103376102-103376103 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs536668955 | chr7:103376147-103376148 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs17155063 | chr7:103376166-103376167 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 31 | rs377166431 | chr7:103376179-103376180 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs372744728 | chr7:103376205-103376206 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs570222570 | chr7:103376235-103376236 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs620243 | chr7:103376272-103376273 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 35 | rs115454772 | chr7:103376281-103376282 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs139248848 | chr7:103376313-103376314 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs536982593 | chr7:103376315-103376316 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs144897713 | chr7:103376328-103376329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs576778276 | chr7:103376347-103376348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs550269592 | chr7:103376364-103376365 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs558948102 | chr7:103376389-103376390 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs183316657 | chr7:103376412-103376413 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs541154467 | chr7:103376413-103376414 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs559532542 | chr7:103376426-103376427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs529826263 | chr7:103376450-103376451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs186485762 | chr7:103376508-103376509 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs621223 | chr7:103376520-103376521 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 48 | rs536138152 | chr7:103376579-103376580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs551757976 | chr7:103376581-103376582 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 50 | rs570105145 | chr7:103376733-103376734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Basal cell lymphoma | 17170743 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Thyroid cancer | 19087340 | CNVD |
| Seminomas | 18059402 | CNVD |
| Testicular cancer | 18059402 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Autism | 19415332 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| Malaria | 21533027 | CNVD |
| Melanoma | 18172304 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| head and neck squamous cell carcinoma | 19289630 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Ewing''s sarcoma | 17952124 | CNVD |
| Autism | 22495311 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Non-small cell lung cancer | 21829676 | CNVD |
| Gastric cancer | 24379144 | CNVD |
| Glioblastoma multiforme | 17002787 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Lissencephaly | 21572526 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Breast cancer | 16397240 | CNVD |
| Acute myeloid leukemia | 16864856 | CNVD |
| Squamous cell cancer | 21044232 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Low-grade fibromyxoid sarcoma | 0 | CNVD |
| Oligodendroglial tumors | 17285580 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Burkitt''s lymphoma | 18698080 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Shwachman-Diamond syndrome | 22934832 | CNVD |
| Colorectal cancer | 19359472 | CNVD |
| Cutaneous malignant melanoma | 17690212 | CNVD |
| Leukemia | 17361228 | CNVD |
| Breast cancer | 16461572 | CNVD |
| Peripheral t-cell lymphoma | 19118030 | CNVD |
| Malignant melanoma | 17690212 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Acute promyelocytic leukemia | 19109227 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Neurodevelopmental disorder | 22521361 | CNVD |
| abortions and stillbirths | 19751515 | CNVD |
| Acute lymphoblastic leukemia | 21980252 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Prostate cancer | 16461572 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
| Burkitt''s lymphoma | 19759907 | CNVD |
| Malignant melanoma | 17260012 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Chronic myeloid leukemia | 21384125 | CNVD |
| Bladder cancer | 21909424 | CNVD |
| Biliary cancer | 19435499 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Splenic marginal zone lymphoma | 21957467 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Primary central nervous system lymphoma | 21088137 | CNVD |
| Liver carcinoma | 19366792 | CNVD |
| T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
| Adenocarcinoma | 19607727 | CNVD |
| Multiple myeloma | 16461302 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Emphysema | 19352772 | CNVD |
| Effusion lymphoma | 18079361 | CNVD |
| Medulloblastoma | 17653508 | CNVD |
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
| Autism | 19401682 | CNVD |
| Neuroticism | 17667963 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Cancer | 19907438 | CNVD |
| Breast cancer | 21364760 | CNVD |
| abnormal development | 18461090 | CNVD |
| Cancer | 20164919 | CNVD |
| Breast cancer | 22522925 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Prostate cancer | 21147910 | CNVD |
| Pancreatic cancer | 17952125 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr7:103374600-103376600 | Enhancers | HUVEC | blood vessel |
| 2 | chr7:103375000-103376600 | Enhancers | Muscle Satellite Cultured Cells | -- |
| 3 | chr7:103375000-103376800 | Enhancers | Hela-S3 | cervix |
| 4 | chr7:103375200-103391000 | Weak transcription | HepG2 | liver |
| 5 | chr7:103375600-103376400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
| 6 | chr7:103375600-103376400 | Enhancers | NH-A | brain |
| 7 | chr7:103375600-103376600 | Enhancers | HMEC | breast |
| 8 | chr7:103375600-103377000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
| 9 | chr7:103375800-103376200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
| 10 | chr7:103375800-103376600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
| 11 | chr7:103375800-103376600 | Enhancers | NHEK | skin |
| 12 | chr7:103376200-103376600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
| 13 | chr7:103376400-103377600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
| 14 | chr7:103377000-103377400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
| 15 | chr7:103377400-103377800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
| 16 | chr7:103377600-103377800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |






